BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2021 12:09:57 PM | Browse: 415 | Download: 664
 |
Received |
|
2021-02-28 22:40 |
|
Peer-Review Started |
|
2021-02-28 22:45 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-16 01:51 |
|
Revised |
|
2021-07-21 02:15 |
|
Second Decision |
|
2021-08-05 03:21 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-08-05 08:57 |
|
Articles in Press |
|
2021-08-05 08:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-09-03 14:25 |
|
Publish the Manuscript Online |
|
2021-09-10 12:09 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Screening strategy for gastrointestinal and hepatopancreatobiliary cancers in cystic fibrosis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Brett Hoskins, Paul Wasuwanich, Ann O Scheimann and Wikrom Karnsakul |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wikrom Karnsakul, MD, Associate Professor, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, United States. wkarnsa1@jhmi.edu |
| Key Words |
Colorectal cancer; CFTR gene; Cystic fibrosis; Gastrointestinal cancer; Hepatopancreatobiliary cancer; Screening |
| Core Tip |
Patients with cystic fibrosis are at a significantly elevated risk for gastrointestinal tract and hepatopancreatobiliary cancers when compared to the general population, especially in those with severe cystic fibrosis transmembrane conductance regulator (CFTR) mutations or who have undergone organ transplantation. As life expectancies continue to increase with CFTR modulators and improved care, cancer screening will become increasingly important. Screening recommendations are largely universal and still emerging. Given the financial burden of universal screening, there is a need for more precise screening based on specific risk factors. In this review, we propose changes to the guidelines for gastrointestinal screening of patients with cystic fibrosis. |
| Publish Date |
2021-09-10 12:09 |
| Citation |
Hoskins B, Wasuwanich P, Scheimann AO, Karnsakul W. Screening strategy for gastrointestinal and hepatopancreatobiliary cancers in cystic fibrosis. World J Gastrointest Oncol 2021; 13(9): 1121-1131 |
| URL |
https://www.wjgnet.com/1948-5204/full/v13/i9/1121.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v13.i9.1121 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
